Brain Miffed by Macrophage Migration Inhibitory Factor

Overview

Journal Int J Cell Biol

Publisher Wiley

Specialty Cell Biology

Date 2012 Sep 14

PMID 22973314

Citations 17

Authors

Nic E Savaskan

Gunter Fingerle-Rowson

Michael Buchfelder

Ilker Y Eyupoglu

Affiliations

Soon will be listed here.

Abstract

Macrophage migration inhibitory factor (MIF) is a cytokine which also exhibits enzymatic properties like oxidoreductase and tautomerase. MIF plays a pivotal role in innate and acquired immunity as well as in the neuroendocrine axis. Since it is involved in the pathogenesis of acute and chronic inflammation, neoangiogenesis, and cancer, MIF and its signaling components are considered suitable targets for therapeutic intervention in several fields of medicine. In neurodegenerative and neurooncological diseases, MIF is a highly relevant, but still a hardly investigated mediator. MIF operates via intracellular protein-protein interaction as well as in CD74/CXCR2/CXCR4 receptor-mediated pathways to regulate essential cellular systems such as redox balance, HIF-1, and p53-mediated senescence and apoptosis as well as multiple signaling pathways. Acting as an endogenous glucocorticoid antagonist, MIF thus represents a relevant resistance gene in brain tumor therapies. Alongside this dual action, a functional homolog-annotated D-dopachrome tautomerase/MIF-2 has been uncovered utilizing the same cell surface receptor signaling cascade as MIF. Here we review MIF actions with respect to redox regulation in apoptosis and in tumor growth as well as its extracellular function with a focus on its potential role in brain diseases. We consider the possibility of MIF targeting in neurodegenerative processes and brain tumors by novel MIF-neutralizing approaches.

Citing Articles

Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine.

Khezrian A, Shojaeian A, Boroujeni A, Amini R Breast Cancer (Auckl). 2024; 18:11782234241276310.

PMID: 39246383 PMC: 11380135. DOI: 10.1177/11782234241276310.

Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia.

Okazaki S, Boku S, Watanabe Y, Otsuka I, Horai T, Morikawa R PLoS One. 2022; 17(3):e0265738.

PMID: 35324982 PMC: 8946738. DOI: 10.1371/journal.pone.0265738.

Bidirectional Crosstalk Between Hypoxia Inducible Factors and Glucocorticoid Signalling in Health and Disease.

Vanderhaeghen T, Beyaert R, Libert C Front Immunol. 2021; 12:684085.

PMID: 34149725 PMC: 8211996. DOI: 10.3389/fimmu.2021.684085.

Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.

Trivedi-Parmar V, Robertson M, Cisneros J, Krimmer S, Jorgensen W ChemMedChem. 2018; 13(11):1092-1097.

PMID: 29575754 PMC: 5990473. DOI: 10.1002/cmdc.201800158.

Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as Usual in Patients with Depression, Anxiety, or Stress and Adjustment Disorders.

Wang X, Sundquist K, Palmer K, Hedelius A, Memon A, Sundquist J Int J Neuropsychopharmacol. 2018; 21(6):513-521.

PMID: 29373661 PMC: 6007313. DOI: 10.1093/ijnp/pyy001.

References

Onodera S, Suzuki K, Matsuno T, Kaneda K, Takagi M, Nishihira J . Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology. 1997; 92(1):131-7. PMC: 1363992. DOI: 10.1046/j.1365-2567.1997.00311.x. View

Iwata S, Hori T, Sato N, Hirota K, Sasada T, Mitsui A . Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. J Immunol. 1997; 158(7):3108-17. View

Bacher M, Meinhardt A, Lan H, Dhabhar F, Mu W, Metz C . MIF expression in the rat brain: implications for neuronal function. Mol Med. 1998; 4(4):217-30. PMC: 2230367. View

Mitchell R, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J . Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A. 2002; 99(1):345-50. PMC: 117563. DOI: 10.1073/pnas.012511599. View

Nguyen M, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D . The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol. 2003; 170(6):3337-47. DOI: 10.4049/jimmunol.170.6.3337. View

Leng L, Bucala R . Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor. Cell Res. 2006; 16(2):162-8. DOI: 10.1038/sj.cr.7310022. View

Hermanowski-Vosatka A, Mundt S, Ayala J, Goyal S, Hanlon W, Czerwinski R . Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry. 1999; 38(39):12841-9. DOI: 10.1021/bi991352p. View

Oda S, Oda T, Nishi K, Takabuchi S, Wakamatsu T, Tanaka T . Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One. 2008; 3(5):e2215. PMC: 2375051. DOI: 10.1371/journal.pone.0002215. View

Jorgensen W, Gandavadi S, Du X, Hare A, Trofimov A, Leng L . Receptor agonists of macrophage migration inhibitory factor. Bioorg Med Chem Lett. 2010; 20(23):7033-6. PMC: 2989669. DOI: 10.1016/j.bmcl.2010.09.118. View

10.

Kleemann R, Kapurniotu A, FRANK R, Gessner A, Mischke R, Flieger O . Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol. 1998; 280(1):85-102. DOI: 10.1006/jmbi.1998.1864. View

11.

Benigni F, Atsumi T, Calandra T, Metz C, Echtenacher B, Peng T . The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest. 2000; 106(10):1291-300. PMC: 381433. DOI: 10.1172/JCI9900. View

12.

Bucala R . Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol. 2001; 79(4):368-75. DOI: 10.1046/j.1440-1711.2001.01024.x. View

13.

Balachandran S, Rodge A, Gadekar P, Yadav V, Kamath D, Chetrapal-Kunwar A . Novel derivatives of ISO-1 as potent inhibitors of MIF biological function. Bioorg Med Chem Lett. 2009; 19(16):4773-6. DOI: 10.1016/j.bmcl.2009.06.052. View

14.

Sugimoto H, Taniguchi M, Nakagawa A, Tanaka I, Suzuki M, Nishihira J . Crystallization and preliminary X-ray analysis of human D-dopachrome tautomerase. J Struct Biol. 1997; 120(1):105-8. DOI: 10.1006/jsbi.1997.3904. View

15.

Xiao D, Dai B, Chen J, Luo Q, Liu X, Lin Q . Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells. Cell Prolif. 2011; 44(6):582-90. PMC: 6495722. DOI: 10.1111/j.1365-2184.2011.00787.x. View

16.

Morand E, Leech M, Bernhagen J . MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov. 2006; 5(5):399-410. DOI: 10.1038/nrd2029. View

17.

Lein E, Hawrylycz M, Ao N, Ayres M, Bensinger A, Bernard A . Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2006; 445(7124):168-76. DOI: 10.1038/nature05453. View

18.

Welford S, Bedogni B, Gradin K, Poellinger L, Powell M, Giaccia A . HIF1alpha delays premature senescence through the activation of MIF. Genes Dev. 2006; 20(24):3366-71. PMC: 1698444. DOI: 10.1101/gad.1471106. View

19.

Shi X, Leng L, Wang T, Wang W, Du X, Li J . CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity. 2006; 25(4):595-606. PMC: 3707630. DOI: 10.1016/j.immuni.2006.08.020. View

20.

Lubetsky J, Swope M, Dealwis C, Blake P, Lolis E . Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry. 1999; 38(22):7346-54. DOI: 10.1021/bi990306m. View